-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains In-Line on Quest Diagnostics, Raises Price Target to $180

Benzinga·04/23/2025 12:58:50
Listen to the news
Evercore ISI Group analyst Elizabeth Anderson maintains Quest Diagnostics (NYSE:DGX) with a In-Line and raises the price target from $175 to $180.